XML 37 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
SELECTED CONSOLIDATED STATEMENTS OF INCOME (LOSS) DATA
12 Months Ended
Dec. 31, 2017
SELECTED STATEMENTS OF OPERATIONS DATA [Abstract]  
SELECTED CONSOLIDATED STATEMENTS OF INCOME (LOSS) DATA
NOTE 12:-
SELECTED CONSOLIDATED STATEMENTS OF INCOME (LOSS) DATA

a.          Financial expenses, net:
 
   
Year ended December 31,
 
   
2017
   
2016
   
2015
 
                   
Income:
                 
                   
Interest on cash equivalents, bank deposits and restricted cash
 
$
447
   
$
1,027
   
$
549
 
Other
   
355
     
81
     
-
 
                         
     
802
     
1,108
     
549
 
Expenses:
                       
                         
Interest with respect to bank credit, loans and other
   
844
     
1,098
     
1,539
 
Exchange rate differences
   
226
     
452
     
3,887
 
Bank charges
   
3,857
     
4,323
     
2,344
 
Other
   
182
     
78
     
22
 
                         
     
5,109
     
5,951
     
7,792
 
                         
Total financial expenses, net
 
$
4,307
   
$
4,843
   
$
7,243
 
 
 b.         Earnings (loss) per share:

The following table sets forth the computation of basic and diluted net earnings (loss) per share:

1.
Numerator:
 
   
Year ended
December 31,
 
   
2017
   
2016
   
2015
 
Numerator for basic and diluted earnings (loss) per share -
                 
Net income (loss) available to holders of Ordinary shares:
                 
From continuing operations
 
$
6,801
   
$
(4,837
)
 
$
(52,134
)
From discontinued operations
   
-
     
-
     
(200
)
                         
     
6,801
     
(4,837
)
   
(52,334
)

2.
Denominator (number of shares in thousands):

Denominator for basic net loss per share -
                 
Weighted average number of shares
   
54,681
     
51,970
     
45,026
 
Add-employee stock options
   
171
     
*)     -
   
*)     -
  
                         
Denominator for diluted net earnings (loss) per share - adjusted weighted average shares assuming exercise of options
   
54,852
     
51,970
     
45,026
 
 
*)
Anti-dilutive.

The earnings (loss) per share for the year ended December 31, 2015 was adjusted, following the rights offering that the Company consummated in March 2016.